Equities

Telo Genomics Corp

Telo Genomics Corp

Actions
  • Price (CAD)0.205
  • Today's Change-0.02 / -8.89%
  • Shares traded62.24k
  • 1 Year change-29.31%
  • Beta1.0633
Data delayed at least 15 minutes, as of Apr 18 2024 20:53 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Events & Activity

  • TELO:CVE price moved over -6.67% to 0.21
  • TELO:CVE price falls below 200-day moving average to 0.21 at 13:13 BST
  • TELO:CVE price rises above 200-day moving average to 0.225 at 14:52 BST
  • TELO:CVE price rises above 200-day moving average to 0.22 at 15:39 BST
  • TELO:CVE trading volume exceeds daily average by +23.42%

Key statistics

On Thursday, Telo Genomics Corp (TELO:CVE) closed at 0.205, 95.24% above the 52 week low of 0.105 set on Apr 02, 2024.
52-week range
Today
0.105Apr 02 20240.335Jun 13 2023
Open0.225
High0.225
Low0.18
Bid0.175
Offer0.205
Previous close0.225
Average volume44.18k
Shares outstanding71.31m
Free float67.33m
P/E (TTM)--
Market cap15.98m CAD
EPS (TTM)-0.0468
CAD
Data delayed at least 15 minutes, as of Apr 18 2024 20:53 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.